EDGESTREAM PARTNERS, L.P. Nektar Therapeutics Transaction History

EDGESTREAM PARTNERS, L.P. portfolio value:

$3.35M
portfolio value

EDGESTREAM PARTNERS, L.P. quarter portfolio value change:

-15.79%
quarter

Nektar Therapeutics 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -1.80% -19.15K shares -702K $3.2 1.04M
Q2 2022 share Increase +71.04% 443.08K shares 692K $3.8 1.06M
Q1 2022 share Increase +1457.71% 583.66K shares 2.82M $5.39 623.70K
Q4 2021 share Increase 0.00% 40.04K shares 541K $14 40.04K